DDRE-21. PNOC015: PHASE 1 STUDY OF MTX110 DELIVERED BY CONVECTION ENHANCED DELIVERY (CED) IN CHILDREN WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) PREVIOUSLY TREATED WITH RADIATION THERAPY

OBJECTIVE: To determine safety and distribution of MTX110 delivered by CED in newly diagnosed DIPG patients. METHODS: DIPG patients (3–21 years) were enrolled after radiation. CED of MTX110 combined with gadoteridol was completed based on dose levels (DL) (30–90 µM with volumes ranging from 3 cc (si...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Mueller, Sabine, Kline, Cassie, Villanueva-Meyer, Javier, Hoffman, Carly, Raber, Shannon, Bonner, Erin R, Nazarian, Javad, Lundy, Shannon, Molinaro, Annette, Prados, Michael, Filbin, Mariella, Gupta, Nalin
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Drug Discovery, Drug Resistance
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651096/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.266
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars